Vancouver, British Columbia--(Newsfile Corp. - January 29, 2024) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian-based life sciences company, is pleased to report that it has received its first shipment of "SOSA", a leading addictions focused herbal treatment. SOSA is a patented, WHO-approved, herbal treatment for opiate addiction that has been administered to more than 30 million... Read More

Vancouver, British Columbia--(Newsfile Corp. - August 15, 2023) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the " Company"), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines, including non-addictive chronic pain and relapse preventing pharmaceutical medicines, is pleased to report that it has completed its acquisition of Medsmart Dispensary Inc, the... Read More

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2023) - Nirvana Life Sciences Inc. (CSE: NIRV) (Nirvana or the "Company"), a western Canadian based life sciences company aimed at developing psychedelic and other natural based medicines, including non-addictive chronic pain and relapse preventing pharmaceutical medicines, is pleased to report that it has entered into a definitive agreement for the acquisition of... Read More